@article{fe0356eac23e4dddb27bcc20c4b21690,
title = "All anti-CD20 monoclonal antibodies have similar efficacy and risks: No",
keywords = "Antibodies, Monoclonal/therapeutic use, Antineoplastic Agents, Humans",
author = "Finn Sellebjerg and {Romme Christensen}, Jeppe",
year = "2022",
month = oct,
doi = "10.1177/13524585221103729",
language = "English",
volume = "28",
pages = "1845--1846",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "Sage Science Press (UK)",
number = "12",
}